Kashmira Date | Senior Director, Medical & Scientific Affairs (Pipeline Vaccines)
pfizer

Kashmira Date, Senior Director, Medical & Scientific Affairs (Pipeline Vaccines), pfizer

Dr. Kashmira Date is a physician, epidemiologist and global health leader with over 20 years of experience and leadership in the public and private sector with clinical development/medical/scientific affairs in infectious diseases, vaccines, epidemiology, real-world evidence, pandemic preparedness, emergency response, global health security, women’s health, and health equity. She currently serves as a Senior Director – Global Respiratory Vaccines and Antivirals (Pipeline Assets), Global Medical Development and Scientific Affairs, Pfizer Vaccines, responsible for the medical/scientific strategy, evidence generation and scientific engagements related to pipeline assets. Prior to her current role, she led the medical and scientific strategy for Covid-19 and Ebola Vaccines at Johnson and Johnson Global Public Health. Dr. Date is an alumnus of CDC’s Flagship Epidemiology Fellowship – Epidemic Intelligence Service (EIS), and led CDC’s new vaccine portfolio on typhoid, cholera and other new vaccines for over a decade before joining the private sector.  She has worked closely with several ministries of health and multiple global health partners (including the World Health Organization, UNICEF, Gavi – the Vaccine Alliance, academia, and, other governmental and non-governmental organizations), led and managed several large-scale projects and initiatives with significant cross-functional and cross-organizational collaborations, authored/co-authored numerous publications and, participated as an expert contributor in multiple panel discussions and forums. She also served as the Chair of the Oral Cholera Vaccine Working Group of the Global Taskforce on Cholera Control (3-year tenure) and represented CDC on numerous global experts working groups and scientific advisory committees. During 2020–2021, she led the Epidemiology Team on CDC’s International Taskforce, Covid-19 Response for over 6 months. In January 2017, she was awarded the “Presidential Early Career Award for Scientists and Engineers (PECASE)” by the Obama Administration, one of the highest honors of the US Government to scientists in their early careers who show exceptional potential for leadership.

Appearances:



Day 1 - Tuesday 14th October @ 11:30

Working Group 4: Rising Stars: Empowering Mid-Career Women in Global Immunisation Leadership

  • What challenges do mid-career women face when transitioning into leadership roles in immunisation?
  • How can we support professional growth and visibility for women in vaccine R&D and policy?
  • Lessons from Women Lift Health & other networks
  • How do gender representation and equity shape immunisation policy and leadership?
  • Mentorship and networking strategies for career advancement
  • Balancing field experience with leadership aspirations

Day 2 - Wednesday 15th October @ 11:30

Integrating Diagnostics and Surveillance in Advancing Disease Burden Estimation

Day 2 - Wednesday 15th October @ 16:30

RSV and Combination Vaccines for Older Adults

last published: 28/May/25 12:25 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

[email protected]

 

Otto Squire
[email protected]

 

TO SPEAK

 

Wing-Yun Cheung
[email protected]

 

MARKETING & PRESS


Jasper Cameron

[email protected]

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.

OSZAR »